Most founders assume a pitch lives or dies on the technology. The panelists on this year’s Designing for Commercialization session at Houston MedTech Oktoberfest made a different case: by the time a team is in the room, investors have usually already decided the science is credible. What they’re actually evaluating is everything sitting quietly around…
Raising capital in medtech has never been harder—and yet some founders consistently move faster, close better rounds, and stay in control of their company’s story. They are not “better pitchers.” They are better sellers. They treat fundraising like a disciplined sales process, not a one-shot performance. They understand that investors are customers, capital is the…
When to Engage with Strategic Partners Build Relationships Early, Without Immediately Seeking Funding Establishing relationships with strategic investors early in your company’s development can be highly beneficial, even if you’re not immediately seeking investment. These relationships develop over time, and early engagement allows you to align long-term interests and facilitate smoother future transactions. By engaging…
The medical device landscape is full of innovation. However, securing funding can feel like navigating through a stormy sky. Avio Medtech is your co-pilot, guiding you through the turbulence. Sharpen Your Value Proposition Investors are drawn to ventures that solve real problems in growing markets. Identify a clear, unmet clinical need and demonstrate how your…
“Can you look at my pitch deck?” We’ve all asked the question. Your pitch deck is critically important…and just a stack of text and images. At Avio, we don’t believe in gatekeeping, so we’re sharing the template we use when building decks for clients and own ventures. You can download the template below. A couple…
The first quarter of 2025 saw notable momentum in medtech venture funding. A total of $3.7 billion was invested in 117 funding rounds, reflecting a 9% year-over-year growth compared to Q1 2024. However, this growth was accompanied by a significant shift in investment patterns: larger rounds were flowing to fewer companies. This investment boom occurred…
Missed the webinar? The recording is now available! Qualified Small Business Stock (QSBS) under Section 1202 of the Internal Revenue Code offers unparalleled tax-saving opportunities for founders and their investors. QSBS has been available for the past 30 years, but its appeal has been enhanced by recent shifts in the tax landscape. The presentation covers…
Addressing and mitigating the risks of medtech development is crucial to attract investors. These risks can be categorized into three main areas: clinical, technical, and market. 1. Clinical Risk Clinical risk refers to the potential for a medical device to cause harm to patients or fail to meet its intended purpose. Investors are cautious about…
Why do investors say no? And say no so often? The Avio team has interviewed over 100 VCs and angels and organized their responses into a presentation, along with suggestions you can use to improve your odds. The presentation was given as a webinar, which you can watch here An AI-generated (and human-edited) summary of…
Avio’s friends at Nocturnal wrote a great post on medtech funding in 2024 and what that could mean for 2025. Avio’s take? The pickup in M&A and (brief) return of IPOs are positives. Challenges with NIH funding, the FDA, and economic uncertainty are negatives. But you knew that already! What to do? Spend small money…